Bristol Myers Squibb (BMY) Interest Coverage Ratio (2012 - 2013)
Bristol Myers Squibb (BMY) reported Interest Coverage Ratio of 7.78 for Q1 2013, down 145.13% year-over-year from 17.24 in Q1 2012, and down 145.13% quarter-over-quarter from 17.24 in Q1 2012.
Bristol Myers Squibb (BMY) Interest Coverage Ratio (2012 - 2013) Analysis & Trends
Bristol Myers Squibb (BMY) has 2 years of Interest Coverage Ratio data on file, last reported at 7.78 in Q1 2013.
- Interest Coverage Ratio for Q1 2013 came in at 7.78, down 145.13% year-over-year; the trailing twelve-month figure through Dec 2013 was 34.56 (up 36.06% YoY), and the FY2012 annual result was 4.5, down 73.29% from the prior year.
- Interest Coverage Ratio slipped to 7.78 in Q1 2013 per BMY's latest filing, from 17.24 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 17.24 in Q1 2012 and troughed at 7.78 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -7.78 |
| Mar 31, 2012 | 17.24 |